Lower serum osteocalcin levels in pregnant drug users and their newborns at the time of delivery

Obstet Gynecol. 1990 Jun;75(6):998-1000.

Abstract

Osteocalcin was evaluated by radioimmunoassay at the time of delivery in mothers and in the umbilical arteries of newborns in a group of pregnant drug users (eight heroin users and seven cocaine users) and compared with findings from a group of normal mothers and their newborns (N = 18). Drug users had lower osteocalcin values than did the normal women (1.3 +/- 0.7 versus 2.7 +/- 0.8 ng/mL, P less than .001); and infants of drug users had lower values than normal infants (14.1 +/- 3.8 versus 19.0 +/- 4.0 ng/mL, P less than .005). The birth weights of drug users' infants were smaller (3160 +/- 402 versus 3591 +/- 374 g, P less than .05) and there was a significant negative correlation (P less than .001) between osteocalcin and drug intake during pregnancy, but no changes in osteocalcin dependent on the type of drug used. These results suggest a toxic effect of these drugs on the osteoblast, which could account for the lower birth weights and skeletal alterations reported in the infants of drug users.

MeSH terms

  • Adolescent
  • Adult
  • Birth Weight
  • Female
  • Fetal Blood / analysis
  • Humans
  • Infant, Newborn
  • Labor, Obstetric / blood*
  • Osteocalcin / blood
  • Osteocalcin / deficiency*
  • Pregnancy
  • Pregnancy Complications / blood*
  • Substance-Related Disorders / blood*

Substances

  • Osteocalcin